Company: SNWV
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038937
Chunk: 82

Company: SANUWAVE Health, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 82
---
Weighted average expected life in years0.350.85Weighted average volatility72%91%Value of underlying shares$32.86$22.76Weighted average risk free interest rate4.27%4.10%Expected dividend yield0%0%A summary of the Level 3 warrant activity for the three and six months ended June 30, 2025, is as follows:(in thousands, except per share data)WarrantsOutstandingFair Valueper ShareWarrant LiabilityFair ValueBalance at March 31, 2025390$33.35 $13,008 Change in fair value-(990)Balance at June 30, 2025390$30.82 $12,018 (in thousands, except per share data)WarrantsOutstanding Fair Valueper ShareWarrant LiabilityFair ValueBalance at December 31, 2024390$20.79 $8,107 Change in fair value-3,911 Balance at June 30, 2025390$30.82 $12,018 

11.        Promissory Notes Payable

Convertible Notes Payable and Convertible Notes Payable, Related Parties - In August 2022, November 2022, May 2023, December 2023, January 2024, and June 2024, the Company entered into Securities Purchase Agreements (the “Purchase Agreements”) for the sale in a private placement of (i) Future Advance Convertible Promissory Notes (the “Notes”) in an aggregate principal amount of $16.2 million in August 2022, $4.0 million in November 2022, $1.2 million in May 2023, $1.9 million in December 2023, $4.6 million in January 2024 related to the conversion of the Asset-Backed Secured Promissory Notes, and $1.3 million in June 2024 (ii) Common Stock Purchase Warrants to purchase an additional 1.9 million shares of common stock with an exercise price of $25.13 per share and (iii) Common Stock Purchase Warrants to purchase an additional 1.9 million shares of common stock with an exercise price of $15.00 per share. Interest expense for the three and six months ended June 30, 2025 totaled $0, and interest expense for the three and six months ended June 30, 2024,